Apatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLC

NCT03201146 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Non Small Cell Lung Cancer
Combination Chemotherapy
Apatinib

Interventions

DRUG: Apatinib
DRUG: AP or AC
DRUG: Apatinib 250mg
DRUG: Apatinib 500mg
DRUG: Apatinib 750mg

Sponsor

West China Hospital

Collaborators

[object Object]